Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze ABCB stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ABCB investment potential.

What is ABCB stock price today?

Get real-time ABCB stock price, historical data, and price charts on Financhill. Track ABCB performance with our advanced analysis tools.

Is ABCB a good investment?

Evaluate ABCB investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ABCB stock?

To buy ABCB stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ABCB?

View detailed market capitalization data and company valuation metrics for ABCB on our comprehensive analysis page.

What is the P/E ratio of ABCB?

Use our fundamental analysis tools to view ABCB P/E ratio and compare valuation metrics with industry peers.

What are ABCB earnings?

View ABCB earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Ameris Bancorp 10K Form

Buy

ABCB
Ameris Bancorp

Last Price:

$79.33

Seasonality Move:

-0.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09	10Q	ABCB/Ameris Bancorp Quarterly
2024-02-28	10K	ABCB/Ameris Bancorp Annual
2023-11-08	10Q	ABCB/Ameris Bancorp Quarterly
2023-08-08	10Q	ABCB/Ameris Bancorp Quarterly
2023-05-08	10Q	ABCB/Ameris Bancorp Quarterly
2023-02-28	10K	ABCB/Ameris Bancorp Annual

Receive ABCB News And Ratings

See the #1 stock for the next 7 days that we like better than ABCB

ABCB Financial Statistics

Sales & Book Value

Annual Sales:	$1.7B
Cash Flow:	$101.2M
Price / Cash Flow:	14.43
Annual Sales:	$59.92
Price / Book:	1.3

Profitability

EPS (TTM):	6.00030
Net Income (TTM):	$412.2M
Gross Margin:	$0
Return on Equity:	10.52%
Return on Assets:	1.54%

Ameris Bancorp Earnings Forecast

Key Ameris Bancorp Financial Ratios

The Gross Profit Margin over the past 35 years for ABCB is 0.00%.
The Selling, General & Administrative Expenses for ABCB have been equal to 0.00% of Gross Profit Margin.
The Interest Expense is 8.11% of Operating Income.
The Net Earning history of ABCB is 24.65% of Total Revenues.
Per Share Earnings over the last 35 years have been positive in 18 years.

Ameris Bancorp Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Banks
Sector:	Financials
Current Symbol:	ABCB
CUSIP:	03076K
Website:	amerisbank.com

Debt

Debt-to-Equity Ratio:	0.18
Current Ratio:	0.05
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	12.95
Forward P/E Ratio:	11.21

ABCB Technical Analysis vs Fundamental Analysis

Buy

Ameris Bancorp (ABCB) is a Buy

Is Ameris Bancorp a Buy or a Sell?

Ameris Bancorp stock is rated a Buy

The current Ameris Bancorp [ABCB] share price is $79.32. The Score for ABCB is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.